A next-generation STING agonist MSA-2: From mechanism to application
- 1 June 2024
- journal article
- review article
- Published by Elsevier in Journal of Controlled Release
- Vol. 371, 273-287
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Tumor Microenvironment‐Selective Sol–Gel Mineralization of ROS‐Responsive Stretchable and Conductive HydrogelAdvanced Functional Materials, 2024
- Multifunctional Mesoporous Polydopamine‐Based Systematic Delivery of STING Agonist for Enhanced Synergistic Photothermal‐ImmunotherapyAdvanced Functional Materials, 2023
- Potentiating the Systemic Immunity by Bacteria‐Delivered Sting Activation in a Tumor MicroenvironmentAdvanced Functional Materials, 2023
- A novel STING agonist with systemic and durable anti‐tumour activityClinical and Translational Discovery, 2023
- Sono‐Driven STING Activation using Semiconducting Polymeric Nanoagonists for Precision Sono‐Immunotherapy of Head and Neck Squamous Cell CarcinomaAdvanced Materials, 2023
- Acid‐Ionizable Iron Nanoadjuvant Augments STING Activation for Personalized Vaccination Immunotherapy of CancerAdvanced Materials, 2023
- Simultaneous Photoactivation of cGAS‐STING Pathway and Pyroptosis by Platinum(II) Triphenylamine Complexes for Cancer ImmunotherapyAngewandte Chemie International Edition, 2022
- Delivery of STING agonists for adjuvanting subunit vaccinesAdvanced Drug Delivery Reviews, 2021
- Identification of α‐Mangostin as an Agonist of Human STINGChemMedChem, 2018
- Type I interferons inhibit the generation of tumor-associated macrophagesCancer Immunology, Immunotherapy, 2009